FDA Approved: FULPHILA — Original Application (Biocon Biologics Inc.)

View source ↗

Summary

FDA approved Fulphila (pegfilgrastim-jmdb) from Biocon Biologics Inc. through an original application to help prevent neutropenia-related infections in cancer p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Chemotherapy-induced Neutropenia
• Neutropenia

Drugs mentioned

• Fulphila (pegfilgrastim)

Snippet

ORIG AP for FULPHILA (PEGFILGRASTIM-JMDB)